Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease.
MIT researchers will partner on interdisciplinary research in human biology and disease.
Glyco enthusiasts from MIT and beyond recently gathered in Bartos Theatre to enjoy presentations of the latest advancements in glycobiology research.
Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.
New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.
Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.
By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
Through the PKG Public Service Center’s social impact internships, MIT students leverage their analytical, technical, and creative problem-solving skills for public good.
The MIT School of Engineering recently honored outstanding faculty, students, and staff with its 2023 awards.
Nine faculty members have been granted tenure in six units across MIT’s School of Engineering.
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.